Fiduciary Alliance LLC Acquires 63,632 Shares of Oscar Health, Inc. $OSCR

Fiduciary Alliance LLC grew its holdings in Oscar Health, Inc. (NYSE:OSCR) by 9.8% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 714,411 shares of the company’s stock after purchasing an additional 63,632 shares during the quarter. Fiduciary Alliance LLC’s holdings in Oscar Health were worth $8,194,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in OSCR. Jones Financial Companies Lllp increased its stake in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio bought a new position in shares of Oscar Health in the first quarter valued at about $30,000. Fifth Third Bancorp lifted its position in Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after buying an additional 1,413 shares in the last quarter. Quarry LP lifted its position in Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after buying an additional 1,469 shares in the last quarter. Finally, Binnacle Investments Inc bought a new stake in Oscar Health during the 2nd quarter worth about $75,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Down 2.9%

Shares of NYSE:OSCR opened at $29.06 on Thursday. Oscar Health, Inc. has a one year low of $10.69 and a one year high of $30.38. The company has a 50 day moving average of $22.48 and a 200-day moving average of $17.19. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The stock has a market cap of $8.76 billion, a price-to-earnings ratio of -49.26, a P/E/G ratio of 2.09 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. During the same period in the previous year, the firm posted $0.92 earnings per share. Oscar Health’s revenue for the quarter was up 52.6% compared to the same quarter last year. On average, sell-side analysts forecast that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Insider Activity

In other news, CAO Victoria Baltrus sold 1,523 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $33,414.62. Following the transaction, the chief accounting officer owned 214,589 shares of the company’s stock, valued at $4,708,082.66. This represents a 0.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Adam Mcananey sold 9,859 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider owned 218,096 shares in the company, valued at $4,785,026.24. This represents a 4.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 189,660 shares of company stock worth $4,283,140. Corporate insiders own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

OSCR has been the subject of several research reports. Wells Fargo & Company set a $20.00 price objective on shares of Oscar Health and gave the company an “equal weight” rating in a research report on Thursday, June 4th. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Robert W. Baird increased their price target on shares of Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Wolfe Research began coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They issued a “peer perform” rating for the company. Finally, Jefferies Financial Group upgraded shares of Oscar Health from an “underperform” rating to a “hold” rating and boosted their price objective for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. Three analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $20.78.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.